NIH Study Reveals New Mechanism of Mutant RAS Genes in Cancer Growth

NIH researchers reveal new insights into mutant RAS genes and their role in tumor growth, highlighting a previously unknown mechanism that could enhance cancer treatment strategies. Published in Nature Cancer, the study shows how mutant RAS proteins contribute to cancer development by transporting nuclear proteins, suggesting broader implications for various cancers. This groundbreaking discovery may lead to more effective combination therapies for RAS-driven malignancies.